Get answers to your digital health challenges

Technology is rapidly influencing the way we prevent, treat and manage diseases. 

With the rise in digital health solutions, there is a growing need to understand and identify where digital tools can add value, and build a business case that can drive both patient and business outcomes.

That’s why we are here.

Get started

HealthXL Spotlight:

Unlocking the Value of Digital Measures in Drug Development

By embracing digital measures, pharma can accelerate drug development, improve patient outcomes. Pharma can and will continue to compete on assets, but should not compete on (digital) endpoints. We require industry collaborations in order to usher in a new era of medicine.

Digital measures have the potential to revolutionise drug development. However, pharma has been slow to fully utilise these measures due to their high costs and lack of standardised applications across therapeutic areas. 

This report presents an expert-led analysis of the state of digital measures in drug development. More specifically, the report delves into:

  • Defining digital measures and the need for standardisation
  • Benefits and challenges of digital measures in drug development
  • Current and future adoption of digital measures in drug development 
  • How pharmaceutical companies can drive the adoption of digital measures  

Download the report to learn what our HealthXL community experts believe is in store for the future of digital measures in drug development and how best to prepare for it. 

Download the free tool nowDownload the free report now

Our Clients

We help clients across the world champion digital health innovation

Hear from our clients

Stefan Harrer

"The quality of work provided by HealthXL was nothing short of outstanding. All deliverables were produced in time, with the highest attention to detail and in a completely transparent and agile manner that allowed my team to understand the status of the work at all times and provide feedback throughout."

Stefan Harrer

CIO, Digital Health CRC

Esther Dyson

‘’What HealthXL are doing is ideal, moderated discussions, interesting people, moderated so that all could contribute.’’

Esther Dyson

Executive Founder at Wellville

Till Bauer

‘’HealthXLs meetings are a brilliant experience. I always follow up with at least one person to carry on the conversation. The meetings are interactive and well moderated. HealthXL brings together a variety of stakeholders and great meetings happen when people share their experiences.’’

Till Bauer

Global Oncology LCM Strategy Director at MSD